Bedel Financial Consulting, Inc. Gsk PLC Transaction History

Bedel Financial Consulting, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$42.05 - $47.77 $8,746 - $9,936	-208 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$40.23 - $47.74 $6,195 - $7,351	154 Added 285.19%	208 $9,000
Q4 2021 Jan 11, 2022	BUY	$38.88 - $45.31 $2,099 - $2,446	54 New	54 $2,000
Q2 2019 Aug 01, 2019	SELL	$39.4 - $42.7 $1,970 - $2,135	-50 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$36.18 - $40.15 $1,809 - $2,007	50 New	50 $2,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $77.7B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.